The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.

Transactions / O•••••••• I•••

••• Locked

Add-on acquisitionclosedadd-onannounced May 21, 2025closed May 21, 2025Fact
What happened
Target
O•••••••• I•••
Platform
P•••••• P•••••••••add-on basis: P•••••• P•••••••••, Inc., a privately held pharmaceutical company focused on the development and commercialization of specialty therapies for specialists and community care providers, that address important medical and public health threats, today announced that the Company has completed its acquisition of O•••••••• I••• (NASDAQ:OPTN). | P•••••• P•••••••••, Inc. is held by B•••••••• on its portfolio page; published on B••••••••'s own news page
Control
Control
Share acquired
unknown
Industry
healthcare / pharma
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Advisory side
  • L•••••Buy-side adviserconfirmed
    “••• Locked”
  • E•••••••Sell-side adviserconfirmed
    “••• Locked”
Side not stated
Evidence
“••• Locked”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026
••• Locked | Private Equity Intelligence | DFX